Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Brain Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Polycythemia Vera 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 8 Glioblastoma 8 Meningioma 7 Leukemia, Myeloid, Acute 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Primary Myelofibrosis 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1

Interventions

Arsenic Trioxide 23 Tretinoin 21 Cytarabine 18 Idarubicin 12 Cyclophosphamide 12 Filgrastim 10 Methotrexate 9 Busulfan 9 Etoposide 8 fludarabine phosphate 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Gemtuzumab 6 Daunorubicin 6 Mitoxantrone 5 Mercaptopurine 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Tacrolimus 4 Antilymphocyte Serum 4 Sorafenib 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2 lintuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02899169 2021-09-08

APL16

First Affiliated Hospital Xi'an Jiaotong University

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡